Nationwide Fund Advisors’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Nationwide Fund Advisors’s Portfolio IDXG Stock Details IDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-16	Closed	-$1K	–	3280
2015 Q4	$1K	Hold	16	–	–	﹤0.01%	3233
2015 Q3	$3K	Hold	16	–	–	﹤0.01%	3253
2015 Q2	$2K	Hold	16	–	–	﹤0.01%	3292
2015 Q1	$2K	Hold	16	–	–	﹤0.01%	3311
2014 Q4	$3K	Hold	16	–	–	﹤0.01%	3216
2014 Q3	$4K	Hold	16	–	–	﹤0.01%	3297
2014 Q2	$7K	Hold	16	–	–	﹤0.01%	3242
2014 Q1	$7K	Hold	16	–	–	﹤0.01%	2973
2013 Q4	$8K	Hold	16	–	–	﹤0.01%	3182
2013 Q3	$8K	Sell	16 -44	-73%	-$21.1K	﹤0.01%	3151
2013 Q2	$28K	Buy	+60	New	+$27.2K	﹤0.01%	3050

Other funds holding IDXG

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nationwide Fund Advisors's IDXG Position: Q1 2016 in Review

Nationwide Fund Advisors sold out of Interpace Biosciences, Inc. Common Stock (IDXG) in Q1 2016, closing a stake of 16 shares — an estimated $1K sold.

Nationwide Fund Advisors first reported a position in IDXG in Q2 2013 and held it in 11 quarters. The position peaked at $28K in Q2 2013. 18 funds tracked by Wall St. Rank hold IDXG as of Q1 2016.

Nationwide Fund Advisors reported no remaining Interpace Biosciences, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
Nationwide Fund Advisors sold 16 Interpace Biosciences, Inc. Common Stock shares in Q1 2016, an estimated $1K.
Nationwide Fund Advisors first reported a position in Interpace Biosciences, Inc. Common Stock in Q2 2013 and held it in 11 quarters.
Nationwide Fund Advisors's Interpace Biosciences, Inc. Common Stock position peaked at $28K in Q2 2013.
18 funds tracked by Wall St. Rank held Interpace Biosciences, Inc. Common Stock as of Q1 2016.

Based on Nationwide Fund Advisors's 13F filing for Q1 2016, filed 5 May 2016.